Apex Biotechnology Corporation

Established in Taiwan in 1997, APEXBIO is a leading diagnostic solution provider. Utilizing our know-how and broad intellectual properties in biosensor development and manufacturing, our products are currently sold in more than 80 countries worldwide and are helping healthcare providers and consumers alike to manage conditions including diabetes, anemia, hyperlipidemia, emergency care, and other chronic and acute conditions.

APEXBIO has been a publicly traded company in Taiwan since 2000, and was the first of its industry peers to achieve this monumental goal.

APEXBIO maintains a dynamic portfolio of diagnostic and monitoring solutions and is actively engaged in research, development, manufacturing and sales worldwide. With a growing portfolio of over 100 international patents, we utilize our development and manufacturing expertise to tailor products that satisfy customer requirements and meet market needs quickly and efficiently. Our manufacturing takes place in two US FDA and EU IVDR approved facilities in Taiwan, both of which have passed numerous US and European regulatory inspections without any deficiencies, and have been certified by Taiwan QMS, ISO 9001 & ISO 13485, FDA and MDSAP. Additionally, our products have received CE, UKCA, US FDA, Taiwan FDA and China NMPA regulatory certification.

APEXBIO leads the market with unsurpassed commitment to quality, providing affordable, turnkey solutions for the healthcare industry.